DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Zinzani PL, Ribrag V, Moskowitz CH. et al.
Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma.
Blood 2017;
130: 267-270
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.